An anticancer therapy targeting ras and other oncogenic signals by inhibition …

Abstract

The present disclosure generally relates to compositions and methods for targeting pro-survival signaling hubs in anoikis-resistant cells, such as anoikis-resistant cancer cells. Embodiments also include methods of changing morphology of cells by inhibiting bleb formation which, in part, reduces …